Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting. With hundreds of sessions, thousands of abstracts, and countless ways to experience the best in hematology, the ASH annual meeting is the world’s premier global hematology event.
Read more in our press release or the presentation above.